Development of new treatments: Our therapeutic antibody-candidates

In an attempt to find new ways to combat diseases, Medicago has been focusing on antibody-based treatments.

Medicago’s teams are working to find antibodies that can effectively treat prevalent and emerging infectious agents. Beyond infectious diseases, Medicago is working to develop treatments for drug addiction and cancer through antibody immunotherapy.

To efficiently respond to emerging diseases and rapidly produce vaccines or therapeutic antibodies in the event of an outbreak, Medicago has developed its Proficia® technology. This technology makes it possible to consider the development of new treatments capable of combating global health problems.

  • Opioide - Medicago


    Medicago is currently working on developing treatments that will help combat opioid abuse or exposure.

  • Cancer


    Medicago is hoping to maximize the potential of its technologies with novel applications such as cancer immunotherapy.